The FDA approved Teva Pharmaceutical Industries Ltd.'s generic version of Aciphex, an acid pump inhibitor made by Japan's Eisai Co. Ltd., a product with annual sales of $1.3 billion. A suit by Eisai against Teva over the drug's patent is pending in federal court in New York.

Full Story:
Globes (Israel)

Related Summaries